The company issued a corrigendum to correct an inadvertent typographical error in its earlier intimation dated 6 November 2026. The correct number of equity shares allotted under its ESOP scheme is 1,20,784 equity shares of face value Rs. 10 each, allotted to 95 eligible allottees. This correction changes the previously reported figure of 1,19,824 shares.
The exercise price for these options was Rs. 10 per share. The total money realized by the exercise of these options was Rs. 12,07,840 (excluding tax).
The paid-up share capital of the company changed as follows:
- Existing paid-up share capital: 7,52,39,438 equity shares (Amount: Rs. 75,23,94,380)
- Post-allotment paid-up share capital: 7,53,60,222 equity shares (Amount: Rs. 75,36,02,220)
The allotment was made under the DEE Employee Stock Option Scheme, 2023 and is in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
The equity shares allotted have the ISIN INE841L01016 and are listed on BSE Limited and the National Stock Exchange of India Limited. The distinctive numbers for these shares range from 80324330 to 80445113.
The new shares will rank pari-passu with all other existing equity shares of the company. There was no premium paid per share, and the shares have no lock-in period.
The company also provided a diluted earnings per share (EPS) figure of Rs. 1.52 per share (standalone basis) for the quarter ended 30th June 2026, pursuant to the issue of these shares.
Additional Announcements:
The filing confirms that a separate grant of 93,920 stock options, including its terms and vesting schedule, remains unchanged from the original intimation.